These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1082 related articles for article (PubMed ID: 25424420)

  • 1. Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis.
    Chen IC; Chiang WF; Huang HH; Chen PF; Shen YY; Chiang HC
    Mol Cancer; 2014 Nov; 13():254. PubMed ID: 25424420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SIRT7 suppresses the epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis by promoting SMAD4 deacetylation.
    Li W; Zhu D; Qin S
    J Exp Clin Cancer Res; 2018 Jul; 37(1):148. PubMed ID: 30001742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Non Coding RNA MALAT1 Promotes Tumor Growth and Metastasis by inducing Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma.
    Zhou X; Liu S; Cai G; Kong L; Zhang T; Ren Y; Wu Y; Mei M; Zhang L; Wang X
    Sci Rep; 2015 Nov; 5():15972. PubMed ID: 26522444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis.
    Li C; Li Q; Cai Y; He Y; Lan X; Wang W; Liu J; Wang S; Zhu G; Fan J; Zhou Y; Sun R
    Cancer Gene Ther; 2016 Sep; 23(9):295-302. PubMed ID: 27492854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIRT1 suppresses the epithelial-to-mesenchymal transition in cancer metastasis and organ fibrosis.
    Simic P; Williams EO; Bell EL; Gong JJ; Bonkowski M; Guarente L
    Cell Rep; 2013 Apr; 3(4):1175-86. PubMed ID: 23583181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of miR-218-GREM1 axis in epithelial-mesenchymal transition of oral squamous cell carcinoma: An in vivo and vitro study based on microarray data.
    Wang Y; Jiang Y; Chen L
    J Cell Mol Med; 2020 Dec; 24(23):13824-13836. PubMed ID: 33107676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-770 promotes oral squamous cell carcinoma migration and invasion by regulating the Sirt7/Smad4 pathway.
    Jia B; Zhang S; Wu S; Zhu Q; Li W
    IUBMB Life; 2021 Jan; 73(1):264-272. PubMed ID: 33326690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-146a promotes proliferation, invasion, and epithelial-to-mesenchymal transition in oral squamous carcinoma cells.
    Wang F; Ye LJ; Wang FJ; Liu HF; Wang XL
    Environ Toxicol; 2020 Oct; 35(10):1050-1057. PubMed ID: 32469461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary tumor-transforming gene 1 (PTTG1) is overexpressed in oral squamous cell carcinoma (OSCC) and promotes migration, invasion and epithelial-mesenchymal transition (EMT) in SCC15 cells.
    Zhang E; Liu S; Xu Z; Huang S; Tan X; Sun C; Lu L
    Tumour Biol; 2014 Sep; 35(9):8801-11. PubMed ID: 24879625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
    Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
    Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of GDF10/BMP3b as a prognostic marker collaborates with TGFBR3 to enhance chemotherapy resistance and epithelial-mesenchymal transition in oral squamous cell carcinoma.
    Cheng CW; Hsiao JR; Fan CC; Lo YK; Tzen CY; Wu LW; Fang WY; Cheng AJ; Chen CH; Chang IS; Jiang SS; Chang JY; Lee AY
    Mol Carcinog; 2016 May; 55(5):499-513. PubMed ID: 25728212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depleting IFIT2 mediates atypical PKC signaling to enhance the migration and metastatic activity of oral squamous cell carcinoma cells.
    Lai KC; Liu CJ; Chang KW; Lee TC
    Oncogene; 2013 Aug; 32(32):3686-97. PubMed ID: 22986528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-130a-3p regulated TGF-β1-induced epithelial-mesenchymal transition depends on SMAD4 in EC-1 cells.
    Tian X; Fei Q; Du M; Zhu H; Ye J; Qian L; Lu Z; Zhang W; Wang Y; Peng F; Chen J; Liu B; Li Q; He X; Yin L
    Cancer Med; 2019 Mar; 8(3):1197-1208. PubMed ID: 30741461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FERMT1 knockdown inhibits oral squamous cell carcinoma cell epithelial-mesenchymal transition by inactivating the PI3K/AKT signaling pathway.
    Wang X; Chen Q
    BMC Oral Health; 2021 Nov; 21(1):598. PubMed ID: 34814915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MTA1 promotes the invasion and migration of oral squamous carcinoma by inducing epithelial-mesenchymal transition via the hedgehog signaling pathway.
    Song Q; Wang B; Liu M; Ren Z; Fu Y; Zhang P; Yang M
    Exp Cell Res; 2019 Sep; 382(1):111450. PubMed ID: 31152708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SIRT1 inhibits TGF-β-induced endothelial-mesenchymal transition in human endothelial cells with Smad4 deacetylation.
    Li Z; Wang F; Zha S; Cao Q; Sheng J; Chen S
    J Cell Physiol; 2018 Nov; 233(11):9007-9014. PubMed ID: 29856490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SATB1 promotes tumor metastasis and invasiveness in oral squamous cell carcinoma.
    Li YC; Bu LL; Mao L; Ma SR; Liu JF; Yu GT; Deng WW; Zhang WF; Sun ZJ
    Oral Dis; 2017 Mar; 23(2):247-254. PubMed ID: 27783844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition.
    Hsiao SY; Weng SM; Hsiao JR; Wu YY; Wu JE; Tung CH; Shen WL; Sun SF; Huang WT; Lin CY; Chen SH; Hong TM; Chen YL; Chang JY
    J Exp Clin Cancer Res; 2023 Feb; 42(1):40. PubMed ID: 36737832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of VHL expression contributes to epithelial-mesenchymal transition in oral squamous cell carcinoma.
    Zhang S; Zhou X; Wang B; Zhang K; Liu S; Yue K; Zhang L; Wang X
    Oral Oncol; 2014 Sep; 50(9):809-17. PubMed ID: 24998140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol attenuates renal injury and fibrosis by inhibiting transforming growth factor-β pathway on matrix metalloproteinase 7.
    Xiao Z; Chen C; Meng T; Zhang W; Zhou Q
    Exp Biol Med (Maywood); 2016 Jan; 241(2):140-6. PubMed ID: 26316584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.